In its latest report, Future Market Insights (FMI) estimates the global bone and joint health supplement market size to reach USD 12.3 billion in 2025. This upward trajectory is a result of growing geriatric population and the high prevalence of orthopedic disorders.
It has gained traction mostly because of growing awareness of general quality of life and how bone and joint health factor into general quality of life. Consumers are more often looking to dietary supplements that deliver nutrients critical for the health of joints and the structural integrity of bones like calcium, vitamin D, glucosamine, chondroitin and collagen.
The world has been witnessing a significant rise in the number of obese people, making fat loss pills one of the most booming segments of the market. In addition to this, the market is extremely competitive with the manufacturers involved also in the strategic investment for innovative ingredients such as collagen peptides to accommodate and adjust itself to the shifting opportunities.
Currently, North America is dominating the market and is also the largest revenue generating region, due to the health-conscious population and the availability of technologically advanced premium dietary supplements machines. Highest growth, by region, is expected in Asia Pacific, owing both to increases in awareness regarding bone & joint health, as well as the very large population of aging in countries such as Japan, China and India.
A few of the key players are: Nature's Bounty Co, NOW Foods, Pfizer Inc, Bayer AG, GlaxoSmithKline (GSK), GNC Holdings, Inc, Reckitt Benckiser Group plc. Companies hoping to compete are outspending on product innovation and strategic partnerships, as well as out-of-the-box marketing targeted at older demographics.
| Attributes | Description |
|---|---|
| Estimated Global Bone and Joint Health Supplement Industry Size (2025E) | USD 12.3 billion |
| Projected Global Bone and Joint Health Supplement Industry Value (2035F) | USD 23.8 billion |
| Value-based CAGR (2025 to 2035) | 6.8% |
In the next decade, product forms including capsules, powders, and liquids are expected to diversify even further based on different consumer preferences. Brands are becoming aligned to ethical consumerism through sustainable sourcing and eco-friendly packaging.
This semi-annual update attempts to show changes in CAGR over two overlapping forecast cycles - 2024 and 2025 - helping stakeholders get a better understanding of the market’s long-term performance.
| Particular | Value CAGR |
|---|---|
| H1 | 6.5% (2024 to 2034) |
| H2 | 6.7% (2024 to 2034) |
| H1 | 6.8% (2025 to 2035) |
| H2 | 6.8% (2025 to 2035) |
The bone and joint health supplement market demonstrated sustained propulsion during the 2024 to 2034 timeline, with a CAGR of 6.5% in the first half, followed by a rise to 6.7% in the latter half. This trend was driven by increasing global awareness of orthopedic health and rising demand for preventive healthcare solutions.
The same uptrend continued for the 2025 to 2035 period. H1 saw a 6.8% CAGR, supported by prioritizing natural health routines and daily joint care by consumers. H2 was 6.8%, indicating strong overall long-term interest in bone and joint health supplements as a lasting part of a holistic supplements approach. Data published in these respective reports reflect a consistent CAGR growth reinforcing increasing consumer usage of these supplements to aid and maintain mobility and quality of life.
The bone and joint health supplement market is expected to grow primarily due to an increased and continued focus on individual healthB nutrition as people coexist with increased risks of bone and jointB chronic diseases. Through strategic brand positioning and sustained product development, the industry is forecasted to maintain its high road for the next decade.
Within Tier 1, the bone and joint health supplement sector (tier 1) is dominated by multinational nutraceuticals and pharmaceuticals companies with established history, availability, and science-backed formulations. These companies provide widely trusted products that include calcium, vitamin D3, magnesium, glucosamine, chondroitin, collagen, and other joint-supportive ingredients.
Schiff Nutrition (a division of Reckitt Benckiser) with its Move Free portfolio is the leader in joint care products in terms of brand sales. Amway’s Nutrilite is also a big player, with its slate of comprehensive bone health supplements featuring plant-based calcium and vitamin D, while Pfizer’s Centrum brand has its joint- and bone-support multivitamins that address a wide swath of the population. These Tier 1 firms leverage efficacy data, well-established pharmacy networks, and robust brand loyalty, often targeting the same aging demographics and active adults.
Tier 2: Regional leaders and mid-tier dietary supplement companies seeking to serve health-conscious consumers looking for premium, specialized solutions. Some of the most widely available brands include NOW Foods, Nature Made and Garden of Life, which offer single or mixed formulas to support bone and joint health, featuring turmeric, MSM, collagen type II and plant-based calcium.
These companies focus on transparency, third-party certifications and clean-label formulations. It is available at e-commerce platforms, health food chains, and specialty retailers. Tier 2 players have found their footholds via ingredient purity, sustainability and reputation for efficacy among wellness-oriented users.
Tier 3 is made up of upstart niche brands addressing very specific consumer concerns like vegan bone health, joint recovery for athletes, or bone strength for women in menopausal transition. Brands like Ritual and Persona Nutrition have personalized supplement packs in their lineups, including bone health based on your specific needs.
Others highlight innovations like fermented calcium, nano-formulated curcumin, or sustainable-source collagen peptides. These companies depend on digital marketing and influencer campaigns, as well as direct-to-consumer sales, to rapidly build community-driven brand trust and visibility.
The rising aging population, awareness of musculoskeletal health, and joint strain due to the lifestyle drive the demand for the bone and joint health supplement market. In all tiers, brands are innovating around clean ingredients, personalized nutrition, and multifunctional products that place joint comfort, mobility, and long-term bone strength in one supplement.
Increase in Elderly Population and Increasing Bone Health Awareness
Shift: And the aging population around the world is raising awareness of osteoporosis, arthritis and general bone degeneration. Older adults are focusing on strong bones, good joint movement, and the ability to move through daily tasks. Even younger consumers - athletes and fitness enthusiasts - are taking a more proactive approach to preventive supplementation.
Strategic Response: For example, leading brands such as Osteo Bi-Flex, Citracal and Move Free have launched high-dose offerings focused on calcium, vitamin D3, collagen and bone/joint support. These days with targeted messaging for older adults and post-menopausal women, who have greater risks of bone density loss.
Demand for Collagen and Plant-Based Joint Support
Shift: Collagen, specifically long used for joint health, this category’s Type II and hydrolyzed peptides predominates, but hybrids with hyaluronic acid and vitamin C are also triumphant in the category, which is also witnessing vegan consumers seeking substitutions for collagen that’ve always been animal-based.
Strategic Response: Vital Proteins and Garden of Life have extended their collagen portfolios to also offer marine and vegan collagen-boosters featuring plant-based amino acid stacks. Other sports nutrition brands have also entered the turmeric, MSM (methylsulfonylmethane) and Boswellia space, which are touted for their inflammation-reducing properties as glucosamine and chondroitin alternatives.
Bone Health Nutrients Found in Functional Foods and Beverages
Shift: Consumers gravitate more toward nutrients delivered in foods and drinks than in pills. Calcium, magnesium, and vitamin K2 in fortified snacks, beverages, and dairy-free substitutes are gaining traction.
Strategic Response: GoodBelly and Core Power are introducing probiotic drinks that come fortified with nutrients that support bone health. Functional shots, as well as dairy-free milk with added calcium and vitamin D from companies like Silk and Ripple, serve to fill the gaps in the plant-based diet.
Clean Label and Allergen-Free Formulations
Shift: Consumers with dietary concerns or preferences are seeking clean-label allergen-free supplements. Gluten-free, soy-free, dairy-free, and sugar-free claims have become essential, too; as has transparency around ingredient sourcing.
Strategic Response: Companies such as NOW Foods and Nordic Naturals have focused on non-GMO, clean-label supplements that highlight traceable ingredients, as part of their strategic response. There are certifications like NSF and USDA Organic as well as third-party lab testing that are shown to put consumer's minds at ease.
Millennials and Gen Z Entrepreneurship in Preventative Health
Shift: More young consumers are taking a preventative approach to health. They are approaching holistic wellness, especially fitness and lifestyle routines, and investing in long-term bone and joint health.
Strategic Response: Goli Nutrition and HUM Nutrition have both unveiled a range of chewables and gummies for joint health containing novel ingredients like astaxanthin, curcumin, and vegan glucosamine. These goods are promoted via social media personalities, subscription boxes and wellness bundles.
Utilizing Personalized Nutrition and Gender-Specific Formulations
Shift: People increasingly want personalization in their supplements, asking for those made for them by age, gender, and lifestyle. We’re seeing women-specific supplements with additional magnesium and K2 for bone density, and men-focused SKUs with joint recovery ingredients gaining momentum.
Strategic Response: Persona Nutrition and Care/of offer personalized packs focused on bone and joints depending on how customers answered the survey. MegaFood and Solgar have introduced new iron-free collagen supplementation products to support women's bone health through hormonal and skeletal changes after menopause.
Development of E-Commerce and Digital Wellness Channels
Shift: Online retailers, health-focused e-commerce platforms and digital pharmacies are driving growth for bone and joint supplements. Shoppers rely on online reviews, expert videos and AI-based wellness quizzes to inform their purchases.
Strategic Response: Both traditional and niche brands sell through Amazon, iHerb, and Thrive Market. Direct-to-consumer brands are integrating wellness education, blogs and even virtual consultations to help shoppers make choices.
Geography Based Trends and Government Impacts
Shift: Regional differences in regulations impact labeling and allowed claims, and even the ingredients. In Europe, health claims approved by EFSA are very high and very rarely constitutes, in the US, claims of structure/function are commonly used. Asian countries such as Japan and South Korea promote functional food-based bone support.
Strategic Response: Consumer and brand interest focus on EFSA or FDA-compliant claims with clinical validation in the USA and Europe. Amway and Fancl, for example, have launched fortified functional foods and supplements in Asia with localized favorites such as soy isoflavones, bamboo silica and fermented calcium.
The following table presents the estimated growth rates of the top five countries expected to lead consumption in the Bone and Joint Health Supplement Market from 2025 to 2035:
| Countries | CAGR (2025 to 2035) |
|---|---|
| USA | 6.4% |
| Germany | 6.7% |
| China | 7.1% |
| Japan | 6.2% |
| India | 7.6% |
Demand for bone and joint health supplements in the USA has been on the rise as the population ages rapidly, and more becomes known about preventative healthcare. Osteoporosis, arthritis, and other mobility-related conditions continue to be widespread among older adults, so there are still plenty of consumers for products such as calcium, vitamin D, magnesium, and glucosamine-chondroitin combinations.
The USA market has a plethora of both over-the-counter and practitioner-recommended products. This is a gentle market for the e-commerce platforms and health food stores with strong demand for clean-label, plant-based, and clinically proven supplements.
Sports nutrition also propels market availability for active and health-conscious individuals looking for joint support for protection and injury recovery. The concept of personalized nutrition has been a contributing factor here, as gender, age, and lifestyle-targeted precise formulations have become more and more popular.
FDA regulatory guidance and Good Manufacturing Practices (GMP) compliance will further help ensure product quality and consumer trust, allowing for continued growth in this space for the long haul.
Germany is among the most mature markets in Europe for bone and joint health supplements. A strong cultural emphasis on natural and holistic wellness, combined with an aging population, keeps up the interest in preventive nutrition.
Supplements with calcium, collagen peptides, MSM, and herbal actives such as turmeric and boswellia are beneficial to older adults, as are younger consumers focused on sustaining long-term mobility.
German consumers also look for value and are concerned about quality, transparency, and science-supported claims in supplements. This preference has led companies to invest in clinically validated formulations, organic sourcing and clean-label ingredients.
Clinics and health retailers dominate at retail point of purchase, although online shopping is increasing and is popular for niche and foreign brands. High awareness regarding bone density monitoring and osteoporosis prevention, as well as robust health insurance and reimbursement systems of the country, allow for a stable market involvement. Nutraceutical companies often collaborate with health care professionals to build trust in supplement use related to maintaining bone and joint health.
With an aging population, evolving dietary patterns, and rapid urbanization, China has one of the fastest CAGRs (compound annual growth rates) for bone and joint supplements[5] in the world. Processed substitutes are usurping traditional Chinese foods, which is causing a shortage of calcium and vitamin D-two essential elements responsible for weaker bones and deteriorating joints.
The growing understanding of osteoporosis and age-related bone decay, alongside rising demand for calcium-rich supplements, fortified products and TCM-based (Traditional Chinese Medicine) bone support remedies have bolstered the sector. Others say collagen, hyaluronic acid, and herbal blends like Eucommia and Morinda are trending up in the premium segment.
China’s growing middle class and better access to health care have also business the adoption of preventive health practices. E-commerce is critical for reaching consumers, especially via cross-border platforms that showcase popular Japanese, Korean and European brands.
The rising focus of the government towards promoting public health and healthy aging strategy in line with national fitness campaigns has created demand for products across urban and semi-urban centers.
| Segment | Value Share (2025) |
|---|---|
| Calcium and Vitamin D Supplements (By Product Type) | 34.7% |
Bone health and joint health supplements industry registered the highest revenue share with calcium and vitamin D supplements as leading products owing to the crucial aspect of maintaining bone density and preventing osteoporosis and osteopenia. The synergy is especially widespread among older adults and postmenopausal women, a cohort experiencing the fastest growth in populations worldwide.
The synergism between calcium and vitamin D and their combined role in enhancing calcium absorption is widely acknowledged by both consumers and healthcare practitioners which continues to drive demand. Brands are improving bioavailability with forms such as calcium citrate and vitamin D3 (cholecalciferol), and adding supporting nutrients such as magnesium and zinc for complete bone care.
Increased awareness around bone health and preventive care have helped OTC products and even physician-recommended calcium and vitamin D supplements (in some cases even omega 3) become part of urban and semi-urban consumers. It is also supported with inclusion in national nutritional programs and the rising incidence of vitamin D deficiency particularly in regions with limited sunlight.
| Segment | Value Share (2025) |
|---|---|
| Online Pharmacies (By Sale Channels) | 22.6% |
The bone and joint health supplements market is witnessing growing demand for online pharmacies as a sales channel over recent years, as the end users find it more convenient, private, and vast range of product offerings. This shift towards e-commerce has accelerated already during the pandemic, with a large proportion of consumers who have bought preventive healthcare products opting for digital channels when purchasing regularly.
In addition, the online channel provides access to global and niche brands; subscription-based delivery models; and personalization based on AI, all of which drive deeper engagement. Platforms, such as Amazon, iHerb, and specialized wellness {E}-commerce websites are experiencing tremendous growth in the joint support supplement market, especially for glucosamine, omega-3s, and herbal blends.
Online pharmacies stand to gain from reflection of wider awareness of health and influencer-marketing on platforms like social media. As the ageing population increasingly understands one aspect of digital literacy, and the access to virtual health consultations is simple enough, online platforms are now increasingly embedded in the decision-making journey for bone and joint care supplements.
The bone and joint health supplement marrket from both nutraceutical powerhouses and pharma holders then make the stratergic such as Nature's Bounty Co., GNC Holdings, Inc., Pfizer Inc. Previously strong portfolios centered on glucosamine, chondroitin, MSM, collagen and more recently calcium, vitamin D3 and omega-3, have been captured within these companies by a maturing population increasingly concerned with aging, osteoporosis, arthritis and joint flexibility.
The success in this market comes from clinical efficacy, consumer trust, diverse benefits, and an ever-growing need for clean-label products as well as science-centered formulations. To differentiate themselves, top brands are also doubling down on personalized nutrition, novel dosage forms (think gummies and soft chews) and enhanced e-commerce presence.
For instance:
Some companies like Reckitt Benckiser Group plc and Bayer AG develop dual-action supplements that incorporate traditional joint support ingredients, such as glucosamine, with ingredient like anti-inflammatory botanicals - all based on their pharmaceutical background. Nestlé Health Science, DSM - far more on clinically validated ingredients and medical nutrition products, often looking toward healthcare professionals and the institutional channels.
The report also specifies that in order to target the emerging sector of joint health, companies such as Puritan's Pride, Dr. Reddy's Laboratories, Angelini Pharma, and GlaxoSmithKline (GSK) are investing towards developing diversified delivery systems, as well as the emerging market with joint solutions that are tailored to consumer needs. They listen, however, we speak, their strategies frequentlyincluding co-research, nutraceutical-pharma convergence and personalityspecific formulations for prevention and treatment.
Due to demographic shifts (aging, sedentary lifestyles, sports-related injuries), musculoskeletal health is a growing global challenge. Companies that have a strong basis in science, brand themselves based on lifestyle, and whose supply chain is well distributed globally are likely to worry far less about competition in this space.
The market is segmented by product type into calcium supplements, vitamin D supplements, glucosamine and chondroitin supplements, omega-3 fatty acid supplements, herbal supplements, and multivitamins with minerals.
Based on form, bone and joint health supplements are available as tablets, capsules, liquids, powders, gummies, and soft gels.
In terms of sales channels, the products are distributed through store-based retail including modern trade, hospital pharmacies, retail pharmacies, and drug stores, as well as through online pharmacies.
Geographically, the market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
Table 1: Global Market Value (US$ million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (MT) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 4: Global Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 5: Global Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 6: Global Market Volume (MT) Forecast by Form, 2019 to 2034
Table 7: Global Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 8: Global Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 9: North America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (MT) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 12: North America Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 13: North America Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 14: North America Market Volume (MT) Forecast by Form, 2019 to 2034
Table 15: North America Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 16: North America Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 17: Latin America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (MT) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 20: Latin America Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 21: Latin America Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 22: Latin America Market Volume (MT) Forecast by Form, 2019 to 2034
Table 23: Latin America Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 24: Latin America Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 25: Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 26: Europe Market Volume (MT) Forecast by Country, 2019 to 2034
Table 27: Europe Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 28: Europe Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 29: Europe Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 30: Europe Market Volume (MT) Forecast by Form, 2019 to 2034
Table 31: Europe Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 32: Europe Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 33: East Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 34: East Asia Market Volume (MT) Forecast by Country, 2019 to 2034
Table 35: East Asia Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 36: East Asia Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 37: East Asia Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 38: East Asia Market Volume (MT) Forecast by Form, 2019 to 2034
Table 39: East Asia Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 40: East Asia Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 41: South Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 42: South Asia Market Volume (MT) Forecast by Country, 2019 to 2034
Table 43: South Asia Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 44: South Asia Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 45: South Asia Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 46: South Asia Market Volume (MT) Forecast by Form, 2019 to 2034
Table 47: South Asia Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 48: South Asia Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 49: Oceania Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 50: Oceania Market Volume (MT) Forecast by Country, 2019 to 2034
Table 51: Oceania Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 52: Oceania Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 53: Oceania Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 54: Oceania Market Volume (MT) Forecast by Form, 2019 to 2034
Table 55: Oceania Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 56: Oceania Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Table 57: Middle East & Africa Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 58: Middle East & Africa Market Volume (MT) Forecast by Country, 2019 to 2034
Table 59: Middle East & Africa Market Value (US$ million) Forecast by Product Type, 2019 to 2034
Table 60: Middle East & Africa Market Volume (MT) Forecast by Product Type, 2019 to 2034
Table 61: Middle East & Africa Market Value (US$ million) Forecast by Form, 2019 to 2034
Table 62: Middle East & Africa Market Volume (MT) Forecast by Form, 2019 to 2034
Table 63: Middle East & Africa Market Value (US$ million) Forecast by Sales Channel, 2019 to 2034
Table 64: Middle East & Africa Market Volume (MT) Forecast by Sales Channel, 2019 to 2034
Figure 1: Global Market Value (US$ million) by Product Type, 2024 to 2034
Figure 2: Global Market Value (US$ million) by Form, 2024 to 2034
Figure 3: Global Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 4: Global Market Value (US$ million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Volume (MT) Analysis by Region, 2019 to 2034
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 9: Global Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 10: Global Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 13: Global Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 14: Global Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 17: Global Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 18: Global Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 21: Global Market Attractiveness by Product Type, 2024 to 2034
Figure 22: Global Market Attractiveness by Form, 2024 to 2034
Figure 23: Global Market Attractiveness by Sales Channel, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ million) by Product Type, 2024 to 2034
Figure 26: North America Market Value (US$ million) by Form, 2024 to 2034
Figure 27: North America Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 28: North America Market Value (US$ million) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 34: North America Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 37: North America Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 38: North America Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 41: North America Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 42: North America Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 45: North America Market Attractiveness by Product Type, 2024 to 2034
Figure 46: North America Market Attractiveness by Form, 2024 to 2034
Figure 47: North America Market Attractiveness by Sales Channel, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ million) by Product Type, 2024 to 2034
Figure 50: Latin America Market Value (US$ million) by Form, 2024 to 2034
Figure 51: Latin America Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 52: Latin America Market Value (US$ million) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 58: Latin America Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 61: Latin America Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 62: Latin America Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 65: Latin America Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 66: Latin America Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Product Type, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Form, 2024 to 2034
Figure 71: Latin America Market Attractiveness by Sales Channel, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Europe Market Value (US$ million) by Product Type, 2024 to 2034
Figure 74: Europe Market Value (US$ million) by Form, 2024 to 2034
Figure 75: Europe Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 76: Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 77: Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 78: Europe Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 79: Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Europe Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 82: Europe Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 83: Europe Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 84: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 85: Europe Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 86: Europe Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 87: Europe Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 88: Europe Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 89: Europe Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 90: Europe Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 91: Europe Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 93: Europe Market Attractiveness by Product Type, 2024 to 2034
Figure 94: Europe Market Attractiveness by Form, 2024 to 2034
Figure 95: Europe Market Attractiveness by Sales Channel, 2024 to 2034
Figure 96: Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: East Asia Market Value (US$ million) by Product Type, 2024 to 2034
Figure 98: East Asia Market Value (US$ million) by Form, 2024 to 2034
Figure 99: East Asia Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 100: East Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 101: East Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 102: East Asia Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 103: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: East Asia Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 106: East Asia Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 107: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 109: East Asia Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 110: East Asia Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 111: East Asia Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 112: East Asia Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 113: East Asia Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 114: East Asia Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 115: East Asia Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 117: East Asia Market Attractiveness by Product Type, 2024 to 2034
Figure 118: East Asia Market Attractiveness by Form, 2024 to 2034
Figure 119: East Asia Market Attractiveness by Sales Channel, 2024 to 2034
Figure 120: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia Market Value (US$ million) by Product Type, 2024 to 2034
Figure 122: South Asia Market Value (US$ million) by Form, 2024 to 2034
Figure 123: South Asia Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 124: South Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 125: South Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 126: South Asia Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 127: South Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 130: South Asia Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 131: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 132: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 133: South Asia Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 134: South Asia Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 135: South Asia Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 136: South Asia Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 137: South Asia Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 138: South Asia Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 139: South Asia Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 140: South Asia Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 141: South Asia Market Attractiveness by Product Type, 2024 to 2034
Figure 142: South Asia Market Attractiveness by Form, 2024 to 2034
Figure 143: South Asia Market Attractiveness by Sales Channel, 2024 to 2034
Figure 144: South Asia Market Attractiveness by Country, 2024 to 2034
Figure 145: Oceania Market Value (US$ million) by Product Type, 2024 to 2034
Figure 146: Oceania Market Value (US$ million) by Form, 2024 to 2034
Figure 147: Oceania Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 148: Oceania Market Value (US$ million) by Country, 2024 to 2034
Figure 149: Oceania Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 150: Oceania Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 151: Oceania Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: Oceania Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: Oceania Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 154: Oceania Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 155: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 156: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 157: Oceania Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 158: Oceania Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 159: Oceania Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 160: Oceania Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 161: Oceania Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 162: Oceania Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 163: Oceania Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 165: Oceania Market Attractiveness by Product Type, 2024 to 2034
Figure 166: Oceania Market Attractiveness by Form, 2024 to 2034
Figure 167: Oceania Market Attractiveness by Sales Channel, 2024 to 2034
Figure 168: Oceania Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East & Africa Market Value (US$ million) by Product Type, 2024 to 2034
Figure 170: Middle East & Africa Market Value (US$ million) by Form, 2024 to 2034
Figure 171: Middle East & Africa Market Value (US$ million) by Sales Channel, 2024 to 2034
Figure 172: Middle East & Africa Market Value (US$ million) by Country, 2024 to 2034
Figure 173: Middle East & Africa Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 174: Middle East & Africa Market Volume (MT) Analysis by Country, 2019 to 2034
Figure 175: Middle East & Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East & Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East & Africa Market Value (US$ million) Analysis by Product Type, 2019 to 2034
Figure 178: Middle East & Africa Market Volume (MT) Analysis by Product Type, 2019 to 2034
Figure 179: Middle East & Africa Market Value Share (%) and BPS Analysis by Product Type, 2024 to 2034
Figure 180: Middle East & Africa Market Y-o-Y Growth (%) Projections by Product Type, 2024 to 2034
Figure 181: Middle East & Africa Market Value (US$ million) Analysis by Form, 2019 to 2034
Figure 182: Middle East & Africa Market Volume (MT) Analysis by Form, 2019 to 2034
Figure 183: Middle East & Africa Market Value Share (%) and BPS Analysis by Form, 2024 to 2034
Figure 184: Middle East & Africa Market Y-o-Y Growth (%) Projections by Form, 2024 to 2034
Figure 185: Middle East & Africa Market Value (US$ million) Analysis by Sales Channel, 2019 to 2034
Figure 186: Middle East & Africa Market Volume (MT) Analysis by Sales Channel, 2019 to 2034
Figure 187: Middle East & Africa Market Value Share (%) and BPS Analysis by Sales Channel, 2024 to 2034
Figure 188: Middle East & Africa Market Y-o-Y Growth (%) Projections by Sales Channel, 2024 to 2034
Figure 189: Middle East & Africa Market Attractiveness by Product Type, 2024 to 2034
Figure 190: Middle East & Africa Market Attractiveness by Form, 2024 to 2034
Figure 191: Middle East & Africa Market Attractiveness by Sales Channel, 2024 to 2034
Figure 192: Middle East & Africa Market Attractiveness by Country, 2024 to 2034
The global bone and joint health supplement market is valued at approximately USD 12.3 billion in 2025.
Sales increased at a CAGR of 5.8% from 2019 to 2023.
Some of the leaders in this industry include Nature's Bounty Co., NOW Foods, Pfizer Inc., Bayer AG, GlaxoSmithKline (GSK), Nestlé Health Science, DSM, Puritan's Pride, Dr. Reddy's Laboratories, and Angelini Pharma.
The North American region is projected to hold a significant revenue share by 2025, driven by an aging population and increased awareness of bone and joint health.
The industry is projected to grow at a forecast CAGR of 6.8% from 2025 to 2035.
Explore Similar Insights
Bone and Joint Health Supplement Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
